3347 — Hangzhou Tigermed Consulting Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual balance sheet for Hangzhou Tigermed Consulting Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	9,986	8,408	7,808	7,483	2,138
Net Total Accounts Receivable
Net Total Receivables	1,435	2,177	3,123	3,734	3,996
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11,646	10,852	11,107	11,344	6,300
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	691	1,142	1,340	1,486	1,696
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	19,506	23,741	27,447	29,681	28,671
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,139	2,413	3,730	4,139	3,662
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	3,387	5,618	7,863	8,654	8,000
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	16,119	18,124	19,583	21,027	20,671
Total Liabilities & Shareholders' Equity	19,506	23,741	27,447	29,681	28,671
Total Common Shares Outstanding